Oral and genital lichenoid reactions associated with circulating autoantibodies to desmoplakins I and II: A novel target antigen or example of epitope spreading?

Journal of the American Academy of Dermatology

Volumn 48, Issue 3, 2003, Pages 433-438

  Oyama, Noritaka ^a   Setterfield, Jane F ^b   Gratian, Matthew J ^a   Bhogal, Balbir S ^a   Shirlaw, Pepe ^b   Challacombe, Stephen J ^b   Black, Martin M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; AZATHIOPRINE; BETAMETHASONE; DESMOPLAKIN; DESMOPLAKIN I; DESMOPLAKIN II; EPITOPE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOIMMUNITY; CASE REPORT; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LICHENOID ERUPTION; MOUTH LESION; MOUTH ULCER; PRIORITY JOURNAL; STEROID THERAPY;

EID: 0037342843     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.198     Document Type: Article

References (25)

1. Samman PD. Lichen planus: an analysis of 200 cases. Trans St Johns Hosp Soc 1961;46:36.
2. Altman J, Perry HO. Variations and course of lichen planus. Arch Dermatol 1961;84:179.
3. Olsen RG, Duplessis DP, Schulz EJ, Camisa C. Indirect immunofluorescence microscopy of lichen planus. Br J Dermatol 1984;110:9-15.
4. Ingafou M, Lodi G, Olsen I, Porter SR. Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens. Oral Surg Oral Med Oral Path Oral Radiol Endod 1997;84:175-8.
5. Mahoney MG, Aho S, Uitto J, Stanley JR. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998;111:308-13.
6. Foedinger D, Anhalt GJ, Boecskoer B, Elbe A, Wolff K, Rappersberger K. Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 1995;181:169-79.
7. Black MM, Bhogal BS. Diagnosis, diagnostic and research techniques. In: Briggaman RA, Wojnarowska F, editors. Management of blistering diseases. Chapter 2. New York: Raven Press; 1990. p. 15-34.
8. Ohta Y, Hashimoto T, Nishikawa T. Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques. Clin Exp Dermatol 1995;20:454-8.
9. Foedinger D, Elbe-Burger A, Sterniczky B, Lackner M, Horvat R, Wolff K, et al. Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol 1998;111:503-10.
10. Lee CW. An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases. Br J Dermatol 2000; 143:821-3.
11. Chorzelski TP, Olszewska M, Jarzabek-Chorzelska M, Jablonska S. Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases. Eur J Dermatol 1998;8:261-5.
12. Lorenzana ER, Rees TD, Glass M, Detweiler JG. Chronic ulcerative stomatitis: a case report. J Peridontol 2000;71:104-11.
13. Dellavalle RP, Egbert TB, Marchbank A, Su LJ, Lee LA, Walsh P. CUSP/p63 expression in rat and human tissues. J Dermatol Sci 2001;27:82-7.
14. Green KJ, Parry DA, Steinert PM, Virata ML, Wagner RM, Angst BD, et al. Structure of the human desmoplakins: implications for function in the desmosomal plaque. J Biol Chem 1990;265:11406-7.
15. Stappenbeck TS, Green KJ. The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J Cell Biol 1992;116:1197-209.
16. Stappenbeck TS, Bornslaeger EA, Corcoran CM, Luu HH, Virata ML, Green KJ. Functional analysis of desmoplakin domains: specification of the interaction with keratin versus vimentin intermediate filament networks. J Cell Biol 1993;123:691-705.
17. Hashimoto T, Watanabe K, Ishiko A, Shimizu H, Hanyaku H, Kimura S, et al. A case of bullous pemphigoid with antidesmo- plakin autoantibodies. Br J Dermatol 1994;131:694-9.
18. Kim SC, Chung YL, Kim J, Cho NJ, Amagai M. Pemphigus vulgaris with autoantibodies to desmoplakin. Br J Dermatol 2001;145: 838-40.
19. Okura M, Tatsuno Y, Sato M, Hashizume S, Kubota Y, Matumura K, et al. Vesicular pemphigoid with antidesmoplakin autoantibodies. Br J Dermatol 1997;16:794-6.
20. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729-35.
21. Kim SC, Kwon YD, Lee IJ, Chang SN, Lee TG. Cloning of the 210kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 1997; 109:365-9.
22. Kiyokawa C, Ruhrberg C, Nie Z, Karashima T, Mori O, Nishikawa T, et al. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol 1998; 111:1236-8.
23. Proby C, Fujii Y, Owaribe K, Nishikawa T, Amagai M. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus. J Invest Dermatol 1999;112:153-6.
24. Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998;110:103-9.
25. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune disease. J Exp Med 1995;181:1597-601.